Patent · US Active

Promoters

US11261464B2 · kind B2 · utility

0Cited by
19References
14Claims
0Family size

Inventors

Key dates

Filing dateSep 18, 2017
Grant dateMar 1, 2022
Priority date
Expiry dateSep 29, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the field of (vector) vaccines, and especially to novel promoter sequences, expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.